{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:13:18Z","timestamp":1778771598568,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"am","delay-in-days":319,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24\\u202FK09849"],"award-info":[{"award-number":["24\\u202FK09849"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.neulet.2025.138315","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T13:46:57Z","timestamp":1752587217000},"page":"138315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Protective effects of empagliflozin against NMDA-induced excitotoxicity in the rat retina"],"prefix":"10.1016","volume":"864","author":[{"given":"Momoka","family":"Ota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akane","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihide","family":"Kashihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7579-5870","authenticated-orcid":false,"given":"Tsutomu","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neulet.2025.138315_b0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10792-017-0795-9","article-title":"Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature","volume":"39","author":"Evangelho","year":"2019","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.neulet.2025.138315_b0010","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3389\/fnins.2019.01172","article-title":"Relationships between neurodegeneration and vascular damage in diabetic retinopathy","volume":"13","author":"Rossino","year":"2019","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.neulet.2025.138315_b0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/jop.1997.13.129","article-title":"Ameliorative effect of MK-801 on retinal ischemia","volume":"13","author":"Lam","year":"1997","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.neulet.2025.138315_b0020","first-page":"1380","article-title":"MK-801 has neuroprotective and antiproliferative effects in retinal laser injury","volume":"38","author":"Solberg","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.neulet.2025.138315_b0025","first-page":"638","article-title":"Retinal glutamate neurotransmission: from physiology to pathophysiological mechanisms of retinal ganglion cell degeneration","volume":"12","author":"Boccuni","year":"2022","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.neulet.2025.138315_b0030","doi-asserted-by":"crossref","first-page":"18471","DOI":"10.1038\/s41598-023-45855-0","article-title":"Molecular mechanisms of NMDA excitotoxicity in the retina","volume":"13","author":"Dvoriantchikova","year":"2023","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.neulet.2025.138315_b0035","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1471-4159.2006.04274.x","article-title":"Pitavastatin prevents NMDA-induced retinal ganglion cell death by suppressing leukocyte recruitment","volume":"100","author":"Nakazawa","year":"2007","journal-title":"J. Neurochem."},{"issue":"17","key":"10.1016\/j.neulet.2025.138315_b0040","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1523\/JNEUROSCI.0831-09.2009","article-title":"Excitotoxic death of retinal neurons in vivo occurs via a non-cell-autonomous mechanism","volume":"29","author":"Lebrun-Julien","year":"2009","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neulet.2025.138315_b0045","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1476-5381.2011.01336.x","article-title":"Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity","volume":"164","author":"Al-Gayyar","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.neulet.2025.138315_b0050","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/glia.23475","article-title":"Microglia mediate non-cell-autonomous cell death of retinal ganglion cells","volume":"66","author":"Takeda","year":"2018","journal-title":"Glia"},{"issue":"10","key":"10.1016\/j.neulet.2025.138315_b0055","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.2337\/db08-1512","article-title":"Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin","volume":"58","author":"Li","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.neulet.2025.138315_b0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.freeradbiomed.2021.02.047","article-title":"AMP-activated protein kinase: a remarkable contributor to preserve a healthy heart against ROS injury","volume":"166","author":"Marino","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.neulet.2025.138315_b0065","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1038\/emm.2016.81","article-title":"Regulation and function of AMPK in physiology and diseases","volume":"48","author":"Jeon","year":"2016","journal-title":"Exp. Mol. Med."},{"issue":"41","key":"10.1016\/j.neulet.2025.138315_b0070","doi-asserted-by":"crossref","first-page":"10475","DOI":"10.1073\/pnas.1802724115","article-title":"Stimulation of AMPK prevents degeneration of photoreceptors and the retinal pigment epithelium","volume":"115","author":"Xu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"9","key":"10.1016\/j.neulet.2025.138315_b0075","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.3390\/ijms22094439","article-title":"Metformin Protects against NMDA-Induced Retinal Injury through the MEK\/ERK Signaling Pathway in Rats","volume":"22","author":"Watanabe","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neulet.2025.138315_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136999","article-title":"Resveratrol dilates arterioles and protects against N-methyl-d-aspartic acid-induced excitotoxicity in the rat retina","volume":"793","author":"Mori","year":"2023","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.neulet.2025.138315_b0085","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1167\/iovs.11-8041","article-title":"Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation","volume":"52","author":"Kubota","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"22","key":"10.1016\/j.neulet.2025.138315_b0090","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"EMPA-REG OUTCOME investigators, Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.neulet.2025.138315_b0095","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/fcp.12548","article-title":"Empagliflozin attenuates transient cerebral ischemia\/reperfusion injury in hyperglycemic rats via repressing oxidative-inflammatory-apoptotic pathway","volume":"34","author":"Amin","year":"2020","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"23","key":"10.1016\/j.neulet.2025.138315_b0100","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.3390\/molecules26237213","article-title":"Neuroprotective effect of SGLT2 Inhibitors","volume":"26","author":"Pawlos","year":"2021","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.neulet.2025.138315_b0105","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jsps.2022.03.005","article-title":"Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of \u03b1-synuclein and Parkin levels in rotenone-induced Parkinson's disease in rats","volume":"30","author":"Ahmed","year":"2022","journal-title":"Saudi. Pharm. J."},{"key":"10.1016\/j.neulet.2025.138315_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148536","article-title":"Sodium-dependent glucose co-transporter-2 inhibitor empagliflozin exerts neuroprotective effects in rotenone-induced Parkinson's disease model in zebrafish; mechanism involving ketogenesis and autophagy","volume":"1820","author":"\u00dcnal","year":"2023","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neulet.2025.138315_b0115","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12974-023-02982-9","article-title":"Empagliflozin targets Mfn1 and Opa1 to attenuate microglia-mediated neuroinflammation in retinal ischemia and reperfusion injury","volume":"20","author":"Yang","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neulet.2025.138315_b0120","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10787-023-01384-w","article-title":"Empagliflozin repurposing in Parkinson's disease; modulation of oxidative stress, neuroinflammation, AMPK\/SIRT-1\/PGC-1\u03b1, and wnt\/\u03b2-catenin pathways","volume":"32","author":"Mohammed","year":"2024","journal-title":"Inflammopharmacology"},{"issue":"17","key":"10.1016\/j.neulet.2025.138315_b0125","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.118.035759","article-title":"Improvement in cardiovascular outcomes with empagliflozin is independent of glycemic control","volume":"138","author":"Inzucchi","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.neulet.2025.138315_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104870","article-title":"Empagliflozin protects heart from inflammation and energy depletion via AMPK activation","volume":"158","author":"Koyani","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.neulet.2025.138315_b0135","first-page":"391","article-title":"Impaired hyaloidal circulation function and uncoordinated ocular growth patterns in experimental retinopathy of prematurity","volume":"39","author":"Berkowitz","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neulet.2025.138315_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176510","article-title":"Role of monocarboxylate transporters in AMPK-mediated protection against excitotoxic injury in the rat retina","volume":"970","author":"Yamagishi","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.neulet.2025.138315_b0145","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2013.08.041","article-title":"ISO-1, a macrophage migration inhibitory factor antagonist, prevents N-methyl-D-aspartate-induced retinal damage","volume":"718","author":"Naruoka","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.neulet.2025.138315_b0150","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/jnr.23358","article-title":"Rapamycin prevents N-methyl-D-aspartate-induced retinal damage through an ERK-dependent mechanism in rats","volume":"92","author":"Ichikawa","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neulet.2025.138315_b0155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.exer.2015.10.016","article-title":"Short-term treatment with VEGF receptor inhibitors induces retinopathy of prematurity-like abnormal vascular growth in neonatal rats","volume":"143","author":"Nakano","year":"2016","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.neulet.2025.138315_b0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40035-024-00431-y","article-title":"SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system","volume":"13","author":"Mei","year":"2024","journal-title":"Transl. Neurodegener."},{"issue":"3","key":"10.1016\/j.neulet.2025.138315_b0165","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20212209","article-title":"Determining the role of SGLT2 inhibition with Empagliflozin in the development of diabetic retinopathy","volume":"42","author":"Matthews","year":"2022","journal-title":"Biosci. Rep."},{"issue":"7","key":"10.1016\/j.neulet.2025.138315_b0170","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/jphp.12571","article-title":"Sodium transport through the cerebral sodium-glucose transporter exacerbates neuron damage during cerebral ischaemia","volume":"68","author":"Yamazaki","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neulet.2025.138315_b0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2017.02.007","article-title":"Sodium influx through cerebral sodium-glucose transporter type 1 exacerbates the development of cerebral ischemic neuronal damage","volume":"799","author":"Yamazaki","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neulet.2025.138315_b0180","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/jnr.21906","article-title":"A Na+\/Ca2+ exchanger isoform, NCX1, is involved in retinal cell death after N-methyl-D-aspartate injection and ischemia-reperfusion","volume":"87","author":"Inokuchi","year":"2009","journal-title":"J. Neurosci. Res."},{"issue":"1\u20132","key":"10.1016\/j.neulet.2025.138315_b0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0169-328X(01)00116-4","article-title":"Characterization of apoptosis-genes associated with NMDA mediated cell death in the adult rat retina","volume":"91","author":"Laabich","year":"2001","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neulet.2025.138315_b0190","first-page":"2629","article-title":"Glutamate receptor activation triggers OPA1 release and induces apoptotic cell death in ischemic rat retina","volume":"14","author":"Ju","year":"2008","journal-title":"Mol. Vis."},{"issue":"16","key":"10.1016\/j.neulet.2025.138315_b0195","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.3390\/app11167385","article-title":"The Relationship between Mitochondria and Neurodegeration in the Eye: a Review","volume":"11","author":"Liu","year":"2021","journal-title":"Appl. Sci."},{"issue":"1","key":"10.1016\/j.neulet.2025.138315_b0200","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12933-022-01532-6","article-title":"Empagliflozin attenuates cardiac microvascular ischemia\/reperfusion injury through improving mitochondrial homeostasis","volume":"21","author":"Zou","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.neulet.2025.138315_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120862","article-title":"Empagliflozin prohibits high-fructose diet-induced cardiac dysfunction in rats via attenuation of mitochondria-driven oxidative stress","volume":"307","author":"Bugga","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.neulet.2025.138315_b0210","article-title":"Empagliflozin ameliorates diabetic cardiomyopathy via attenuating oxidative stress and improving mitochondrial function","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neulet.2025.138315_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.103010","article-title":"Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress","volume":"69","author":"Cai","year":"2024","journal-title":"Redox Biol."},{"issue":"19","key":"10.1016\/j.neulet.2025.138315_b0220","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.3390\/cells11193107","article-title":"Anti-inflammatory properties of the SGLT2 inhibitor empagliflozin in activated primary microglia","volume":"11","author":"Heimke","year":"2022","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.neulet.2025.138315_b0225","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/dom.12073","article-title":"Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes","volume":"15","author":"Heise","year":"2013","journal-title":"Diabetes Obes. Metab."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394025002034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394025002034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:48:02Z","timestamp":1777553282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394025002034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":45,"alternative-id":["S0304394025002034"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2025.138315","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of empagliflozin against NMDA-induced excitotoxicity in the rat retina","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2025.138315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"138315"}}